Cefadroxil Dosing
For adults, cefadroxil is dosed at 1-2 grams daily (either once daily or divided twice daily) depending on infection severity, while children receive 30 mg/kg/day divided every 12 hours, with mandatory dose adjustments in renal impairment based on creatinine clearance. 1
Adult Dosing
Standard Infections
- Uncomplicated UTIs (cystitis): 1-2 g daily, given as single dose or divided twice daily 1
- Complicated UTIs: 2 g daily in divided doses (1 g every 12 hours) 1
- Skin and soft tissue infections: 1 g daily, single dose or divided twice daily 1
- Pharyngitis/tonsillitis (Group A Strep): 1 g daily for 10 days, single dose or divided twice daily 1
The FDA label provides clear flexibility between once-daily and twice-daily dosing for most indications 1. However, recent PK/PD data from 2024 suggests that twice-daily dosing (40 mg/kg/dose up to 1,500 mg) optimizes target attainment for serious infections like musculoskeletal infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) 2. For moderate-to-severe SSTIs, higher doses are preferable to optimize pharmacodynamic parameters 3.
Pediatric Dosing
All pediatric indications: 30 mg/kg/day 1
- UTIs: Divide every 12 hours 1
- Pharyngitis, tonsillitis, impetigo: Single daily dose OR divided every 12 hours 1
- Other skin/soft tissue infections: Divided every 12 hours 1
- Duration for streptococcal infections: Minimum 10 days 1
The 2024 pediatric PK study supports 40 mg/kg/dose (maximum 1,500 mg) twice daily for serious musculoskeletal infections to achieve optimal free drug concentrations above MIC for 40% of the dosing interval 2. This represents a higher dose than the standard FDA recommendation and should be considered for severe infections.
Renal Impairment Adjustments
Initial loading dose: 1,000 mg, then adjust maintenance dosing based on creatinine clearance 1:
- CrCl >50 mL/min: No adjustment needed (standard dosing)
- CrCl 25-50 mL/min: 500 mg every 12 hours
- CrCl 10-25 mL/min: 500 mg every 24 hours
- CrCl <10 mL/min: 500 mg every 36 hours
These adjustments prevent drug accumulation, as cefadroxil is substantially excreted renally 1. Even in severe renal failure (CrCl <10 mL/min), urinary concentrations remain adequate for susceptible bacteria 4. The elimination half-life increases significantly with declining renal function, necessitating these interval extensions 4.
Severe Penicillin Allergy Considerations
Cefadroxil is contraindicated in patients with immediate hypersensitivity reactions (anaphylaxis, urticaria, angioedema) to penicillins or cephalosporins 5.
For patients with documented severe penicillin allergy:
- Do NOT use cefadroxil or any first-generation cephalosporin 5
- Alternative agents include clindamycin, doxycycline, or trimethoprim-sulfamethoxazole depending on the infection 5
A critical caveat: While cefazolin (a related first-generation cephalosporin) has unique side chains that minimize cross-reactivity and may be used cautiously with appropriate monitoring in some penicillin-allergic patients 6, 7, cefadroxil has documented cases of severe laryngeal angioedema even in patients with no prior penicillin allergy history 8. This underscores the need for extreme caution.
For patients with non-immediate, uncomplicated delayed-type reactions (e.g., maculopapular rash without systemic symptoms), cephalosporins may be considered acceptable, but this decision requires careful risk-benefit assessment and is not specifically addressed for cefadroxil in the guidelines 5.
Important Clinical Pearls
- Administration: May be given without regard to meals, though food may reduce GI side effects 1
- Suspension storage: Refrigerate after reconstitution; discard after 14 days 1
- Complete the course: Emphasize to patients that stopping early increases resistance risk 1
- Elderly patients: More likely to have decreased renal function; monitor creatinine clearance and adjust doses accordingly 1
- Longer half-life advantage: Cefadroxil's half-life (1.61 hours) is longer than cephalexin (1.10 hours), supporting less frequent dosing and potentially improved adherence 2